Immunotherapy Combined With Y-90 and SBRT for Colorectal Liver Metastases
收藏NIAID Data Ecosystem2026-03-11 收录
官方服务：
资源简介：
This study is evaluating the combination of Y-90 radioembolization followed by SBRT with the immunotherapy drugs, durvalumab and tremelimumab, to improve disease control of liver metastases for patients with microsatellite stable colorectal cancer.
创建时间：
2019-08-15
